Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program
Raffaele Campisi,1 Claudia Crimi,1 Santi Nolasco,2 Bianca Beghè,3 Leonardo Antonicelli,4 Gabriella Guarnieri,5 Nicola Scichilone,6 Morena Porto,2 Luigi Macchia,7 Giulia Scioscia,8 Maria Pia Foschino Barbaro,8 Alberto Papi,9 Nunzio Crimi1,2 1Respiratory Medicine Unit, A.O.U. Policlinico &a...
Main Authors: | Campisi R, Crimi C, Nolasco S, Beghè B, Antonicelli L, Guarnieri G, Scichilone N, Porto M, Macchia L, Scioscia G, Foschino Barbaro MP, Papi A, Crimi N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/real-world-experience-with-dupilumab-in-severe-asthma-one-year-data-fr-peer-reviewed-fulltext-article-JAA |
Similar Items
-
Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
by: Giorgio Walter Canonica, et al.
Published: (2021-05-01) -
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
by: Pelaia C, et al.
Published: (2021-09-01) -
Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
by: Vingopoulos F, et al.
Published: (2020-07-01) -
The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
by: Mary Kathryn Abel, AB, et al.
Published: (2021-04-01) -
Experience of using dupilumab in the treatment of severe asthma
by: G. L. Ignatova, et al.
Published: (2020-09-01)